← Back to Clinical Trials
Recruiting NCT04607538

NCT04607538 The Faroese Knee Cohort: Etiology and Long-term Implications of Trochlear Dysplasia and Patellar Dislocations.

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT04607538
Status Recruiting
Phase
Sponsor Hvidovre University Hospital
Condition Patellar Dislocation
Study Type OBSERVATIONAL
Enrollment 100 participants
Start Date 2022-03-01
Primary Completion 2024-11-01

Eligibility & Interventions

Sex All sexes
Min Age 15 Years
Max Age 20 Years
Study Type OBSERVATIONAL
Interventions
No intervention is made

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 100 participants in total. It began in 2022-03-01 with a primary completion date of 2024-11-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The investigators intend to establish a national cohort including all persons in the ages from 15-20 years old with patellar instability (PI) or a prior knee injury (ACL-ruptur or meniscus damage) . The cohort will be nicknamed "The Faroese Knee Cohort". The overall aim is to investigate two groups. 1. The patella instability group, in which we intend to investigate the following. * Prevalence of patellar dislocation and trochlear dysplasia in the Faroe Islands. * Risk factors for patellar dislocations- * Heredity of trochlear dysplasia. * If there is a specific gene responsible for the development of trochlear dysplasia. * The development of retropatellar artrhosis, its onset and its impact on quality of life and function, 2. Knee injury group (ACL-ruptur or meniscus injury) * The prevalence of ACL-rupture and/or meniscus injury in this specific group in the Faroe Islands. * The impact on quality of life and function.

Eligibility Criteria

Inclusion Criteria: * Age between 15-20 years at the start of patient enrolment. * The feeling of patellar instability, or patellar dislocation/near-dislocation. * The person has to be from the Faroe Islands. * All persons under the age of 18 must get written consent by their parents Exclusion Criteria: * Terminal illness * Mental disabilities and illness, meaning that the patient cannot independently answer the PROM´s and cooperate to the clinical investigation.

Contact & Investigator

Central Contact

Niclas Eysturoy, MD

✉ nicey@ls.fo

📞 +298 252629

Frequently Asked Questions

Who can join the NCT04607538 clinical trial?

This trial is open to participants of all sexes, aged 15 Years or older, up to 20 Years, studying Patellar Dislocation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT04607538 currently recruiting?

Yes, NCT04607538 is actively recruiting participants. Contact the research team at nicey@ls.fo for enrollment information.

Where is the NCT04607538 trial being conducted?

This trial is being conducted at Hvidovre, Denmark.

Who is sponsoring the NCT04607538 clinical trial?

NCT04607538 is sponsored by Hvidovre University Hospital. The trial plans to enroll 100 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology